BG Medicine, Inc.
BGMD
$0.00
$0.000.00%
| 12/31/2015 | 09/30/2015 | 06/30/2015 | 03/31/2015 | 12/31/2014 | |
|---|---|---|---|---|---|
| Net Income | 34.24% | 34.08% | 28.69% | 42.67% | 49.12% |
| Total Depreciation and Amortization | -33.59% | 244.83% | -12.12% | -7.30% | -20.61% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 76.15% | 52.59% | 25.90% | -31.15% | -49.35% |
| Change in Net Operating Assets | 97.87% | 117.53% | 100.34% | 56.74% | 17.56% |
| Cash from Operations | 55.10% | 62.15% | 52.99% | 46.55% | 46.58% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -35.00% | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | 176.47% | 111.61% | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 33.39% | 8.39% | -9.08% | -34.94% | -76.87% |
| Issuance of Common Stock | -73.01% | -73.01% | -100.00% | 1,125.00% | -33.08% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -295.06% | -293.16% | 100.00% | -12,050.00% | 15.92% |
| Cash from Financing | -76.73% | -101.41% | -180.91% | 237.56% | -55.87% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 28.39% | 27.10% | -40.44% | 84.32% | 27.94% |
